NGVT Ingevity
Ingevity earnings company data as of 3:59 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 1.56 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by NGVT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $234K sold by 2 insiders outside a trading plan
- $1.5M sold by 1 insider under 10b5-1 plans
-
David H Li CEOPlanned sale$765K 10,092 shares at $75.77 7.7% of stakeTraded Aug 14–18 Filed Aug 18
-
David H Li CEOPlanned sale$762K 10,000 shares at $76.18 7.1% of stakeTraded Aug 12–13 Filed Aug 14
-
Ryan C. Fisher SVP, Gen. Counsel & SecretarySale$200K 2,709 shares at $73.72 15% of stakeTraded Aug 3 Filed Aug 4
-
Terrance M Dyer SVP, Chief HR OfficerSale$34K 496 shares at $68.49 6.4% of stakeTraded May 28 Filed Jun 1
Also filed in the last 12 months, not counted as buying or selling: 31 stock grants and 31 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.